BBIO Financials

BridgeBio Pharma Inc - Financial statements & key metrics

Stock Price

$76.65

Market Cap

$13.24B

P/E Ratio

-26.6

EPS

$-2.88

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$221.90M

Gross Profit

Operating Income

Net Income

$-543.35M

EPS (Diluted)

$-2.88

Balance Sheet Highlights

Total Assets

$919.34M

Total Liabilities

$2.38B

Shareholders Equity

Cash & Equivalents

$681.10M

Total Debt

Profitability Metrics

Net Margin

-244.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is BBIO revenue?

BBIO's most recent quarterly revenue was $221.90M. Annual revenue can be calculated by summing the four most recent quarters.

Is BBIO profitable?

BBIO reported a loss of $543.35M in the most recent quarter. The net profit margin is -244.9%.

What is BBIO market cap?

BBIO has a market capitalization of $13.24B, making it a large-cap stock.

Does BBIO have debt?

View BBIO's balance sheet for debt information.

What is BBIO cash flow?

Cash flow data is available in the full financial statements.